Slide 1: FY26 Full Year Results
FY26 Full Year Results August 2026
Slide 2: Pro Medicus: Leaders in Enterprise Imaging/Radiology Information Systems
Pro Medicus (ASX:PME) | Leaders in Enterprise Imaging/Radiology Information Systems GROUP HQ EU HQ/R&D North American HQ Melbourne, AUS Berlin, Germany San Diego, CA USA
Slide 3: Table of Contents
Table of Contents • FY26 Highlights 4 • Financials 6 • Contract Wins 14 • Contract Renewals 21 • Implementations 23 • Investments & Partnerships 28 • AI Progress 31 • Products 36 • Clinical Outcomes 52 • Growth Strategy 54 • RSNA 2025 61 • Summary 65 FY26 Full Year Results | Year ended 30 June 2026
Slide 4: FY26 Highlights
% progmedicus — Visace IMAGING’ FY26 Highlights prosmedicus — Visace IMAGING’
Slide 5: FY26 Highlights
FY26 Highlights • Financials – Underlying Revenue +28%1, Underlying EBIT +31%2, Underlying NPAT +33%2, Cash Conversion 91%, Cash & Other Financial Assets $252m + 20% • Contract Wins – 1 Europe, 9 US contracts signed worth total of $407m • Renewals – Renewed 6 out of 6 contracts on long term, 5-year
Slide 6: Financials
% progmedicus — Visace IMAGING’ Financials prosmedicus — Visace IMAGING’
Slide 7: Results FY26 Financial Performance
Results FY26 Financial Performance Revenue Underlying EBIT Underlying EBIT Margin Underlying NPAT $261.7M $196.1M 74.9% $144.7M up 22.9% up 24.4% up 0.9pt up 24.1% Group earnings summary Revenue by region A$m FY26 FY25 Change % A$m FY26 FY25 Change % Revenue 261.7 213.0 48.7 22.9% Australia 19.0 17.
Slide 8: Results FY26 Constant Currency
Results FY26 Constant Currency Revenue (constant currency) Underlying EBIT (constant currency) FX Impact on Revenue FX Impact on EBIT $273.5M $206.0M $(11.8)M $(9.9)M up 28.4% underlying up 30.6% underlying AUD/USD 0.6779 vs 0.6472 AUD/EUR 0.5812 vs 0.5950 FY26 FY26 constant FY25 Underlying Underlyi
Slide 9: Results FY26 Balance Sheet and Shareholder Returns
Results FY26 Balance Sheet and Shareholder Returns Cash Reserves Cash and Financial Assets NTA per Share Total Dividend (franked) $216.1M $252.3M $4.10 69.0c up 23.8% up 19.7% up 81.4% up 25.5% Capital position Dividends per share (franked) A$m FY26 FY25 Change % Cents per share FY26 FY25 Change % C
Slide 10: Results FY26 Five-year Revenue Growth
Results FY26 - Five-year Revenue Growth Revenue by revenue stream 300 29% CAGR 34.8 200 26.1 22.2 100 21.1 192.1 18.4 158.3 121.9 93.5 67.5 0 FY22 $93m FY23 $125m FY24 $161m FY25 $213m FY26 $262m Exam / licence Support Archive data migration Professional services Revenue by type, FY22 to FY26 | A$m
Slide 11: Results FY26 Revenue Split and Forward Contracts
Results FY26 Revenue Split and Forward Contracts Revenue by geography Forward contracts recurring revenue next five years 300 1,500 27% CAGR 29% CAGR 1.3B 1,200 200 948M 900 624M 236.8 600 100 190.9 140.6 300 0 0 FY24 $161m FY25 $213m FY26 $262m Jun 24 Jun 25 Jun 26 North America Europe Australia Re
Slide 12: Results FY26 Total Contract Value Signed
Results FY26 Total Contract Value Signed 800 Total contract value by year A$m New Renewals Total FY22 100.0 57.0 157.0 600 FY23 88.5 15.5 104.0 FY24 245.0 19.0 264.0 FY25 511.0 169.0 680.0 400 FY26 407.0 141.0 548.0 Five years 1,351.5 401.5 1,753.0 200 FY26 in context Second highest year on record,
Slide 13: Financial Performance – 5 Years
Financial Performance – 5 Years Revenue Reported FY22 FY23 FY24 FY25 FY26 CAGR (%) Australia 14.6 15.9 16.9 17.7 19.0 5% Europe 5.2 4.4 4.1 4.4 5.9 3% North America 73.7 104.6 140.6 190.9 236.8 26% Total 93.5 124.9 161.5 213.0 261.7 23% Revenue Constant Currency FY22 FY23 FY24 FY25 FY26 CAGR (%) Aus
Slide 14: Contract Wins
% progmedicus — Visace IMAGING’ Contract Wins prosmedicus — Visace IMAGING’
Slide 15: Contract Wins
Contract Wins Total Contract Value Signed New Contracts TCV Renewals + Additions Implementations FY26: $551m FY26: $407m FY26 $144m: $141m + $3m FY26: 16 10 new, 6 renewals 10 contracts - 9 US, 1 Europe 6 renewals + 1 WL addition (VISN23) Go-lives incl. four Trinity cohorts New contracts: $407m UCHe
Slide 16: Contract Win – UCHealth Colorado
Contract Win – UCHealth Colorado • A$170M 10-year deal, 2nd largest in company’s history • “Full Stack + 1” – Includes Visage 7 | Cardiology Imaging offering • Highly respected hospital system based in Aurora Colorado • University of Colorado Hospital – AMC Medical school and research center for Col
Slide 17: Contract Win – Heidelberg University
Contract Win – Heidelberg University • A$10M – 5-year deal • Top German medical school and teaching hospital • Affiliated German Cancer Research Institute largest cancer research centre in Europe • Increased PME footprint in Germany/Europe • Went live in April 2026
Slide 18: Contract Win – Radiology Associates North Texas
Contract Win – Radiology Associates North Texas (RANT) • A$44M – 5-year deal • Private, remote reading group based in North Texas • One of the nation’s largest and most innovative private practice radiology groups • Breast Imaging live in April 2026 • Full go live – August 2026 • Greatly strengthens
Slide 19: Contract Win – University of Maryland
Contract Win – University of Maryland • A$23M – 5-year deal • Academic Medical Center • Based in Baltimore, Maryland • Was a key reference site for Visage competitor • 12 hospitals across Maryland, including the University of Maryland Medical Center and world-renowned R Adams Cowley Shock-Trauma Cen
Slide 20: Contract Win – Beth Israel Lahey Health
Contract Win – Beth Israel Lahey Health • A$90M – 7-year deal, 4th largest in company’s history • “Full Stack” • Highly respected hospital system based in Boston, Massachusetts • Academic medical centers and teaching, community and specialty hospitals • Fourteen (14) hospitals and will include the w
Slide 21: Contract Renewals
% progmedicus — Visace IMAGING’ Contract Renewals prosmedicus — Visace IMAGING’
Slide 22: Contract Renewals
Contract Renewals Total Contract Value Signed New Contracts TCV Implementations Largest Contract FY26: $551m FY26: $407m FY26: 16 FY26: $170m 10 new, 6 renewals | FY25 $680m 10 contracts | FY25 $511m Go-lives incl. four Trinity UCHealth Colorado, 10 years Renewals and additions: $144m $37m / 5 years
Slide 23: Implementations
% progmedicus — Visace IMAGING’ Implementations prosmedicus — Visace IMAGING’
Slide 24: Implementations
Implementations Total Contract Value Signed New Contracts TCV Implementations Largest Contract FY26: $551m FY26: $407m FY26: 16 FY26: $170m 10 new, 6 renewals | FY25 $680m 10 contracts | FY25 $511m Go-lives incl. four Trinity UCHealth Colorado, 10 years Implementations: 16 go-lives 16 Go-Lives compl
Slide 25: Implementations – Progress at 30 June 2026
Implementations – Progress at 30 June 2026 Announced Customer Contract Value (A$) Term Implied Annualised (A$) Go- Live Target Progress % Implemented FY26 28-Nov-24 Trinity $330m 10 years $33m 4Q CY25 On Schedule 75% 04-Dec-24 Lurie's Children's Hospital $5m 7 years $1m 3Q CY25 On Schedule 100% 16-J
Slide 26: Implementations – Trinity Health Update
Implementations – Trinity Health Update • Contract signed – November 2024 • Arguably, the largest CloudPACS in the world • National footprint, centralized in the cloud, high availability • Centralized workflow platform across the entire network, enables national reading across time zones • Phased im
Slide 27: Implementations – Competitive Advantage
Implementations – Competitive Advantage • All implementations on or ahead of schedule • Fast track methodology continues to deliver • Large scale projects completed in under 1/4 to 1/5 the time of industry norm • Delivers huge savings for client • Free(s) PME staff for other jobs • Reduces barrier t
Slide 28: Investments & Partnerships
% progmedicus — Visace IMAGING’ Investments & Partnerships prosmedicus — Visace IMAGING’
Slide 29: Investment – 4DMedical (ASX:4DX)
Investment – 4DMedical (ASX:4DX) • $10m investment – hybrid debt and equity • 2-year term maturing 31 July 2027 • Coupon rate of 12.5% PA • $20m payout if share price doubles • Equity component if share price more than doubles (>$0.48) • Unrealised gain ~$172m as of 30 June 2026
Slide 30: Investment – Echo iQ (ASX:EIQ)
Investment – Echo iQ (ASX:EIQ) • A$10m initial investment in secured unlisted convertible notes at A$1.05 per note • Option to invest another A$10m upon Echo IQ receiving FDA clearance of EchoSolv HF • 2-year term maturing after issue date • Coupon rate of 12.5% PA • Options – 0.75 unlisted options
Slide 31: AI Progress
% progmedicus — Visace IMAGING’ Al Progress prosmedicus — Visace IMAGING’
Slide 32: AI in Healthcare
AI in Healthcare • Healthcare and AI – ideally matched • Imaging at the vanguard of healthcare AI • Highly regulated environment – FDA, CE, TGA • Mission critical - zero downtime/zero errors • AI must be imbedded in complex workflows to be used by clinicians • AI must be trusted – can’t be a black b
Slide 33: Visage 7 | AI
Visage 7 | AI • PME/Visage ideally placed to benefit from AI • Visage 7.0 desktop the “gate keeper” for image-based AI integration • Visage used by ~ 11% of US market and growing • Ability to imbed AI into core Visage 7 offering • Capital light strategy sourcing best in breed algorithms
Slide 34: Visage 7 | AI
Visage 7 | AI • Breast cancer detection algorithm co-developed with NYU – commercialisation pending FDA clearance • Investment in Elucid for Cardiac CT AI • Investments in 4DMedical and Echo IQ • Research collaboration agreements with UCSF, Mayo, NYU and others • Growing number of 3rd party AI integ
Slide 35: AI – Research Leadership
AI – Research Leadership Malte Westerhoff, PhD Detlev Stalling, PhD MingDe Lin, PhD Global Chief Technology Officer Head of Development Clinical Research Manager, North America
Slide 36: Products
% progmedicus — Visace IMAGING’ Products prosmedicus — Visace IMAGING’
Slide 37: Visage 7 One Platform – All Imaging
Visage 7 One Platform – All Imaging • Single viewer for ALL images in the medical record (EHR) – Enterprise Imaging • Radiology/Cardiology/Pathology • Non-radiology– reflected light – hi-res photos & videos • Same code base as Visage 7 platform • Increases Visage value proposition • Growth opportuni
Slide 38: Speed | Functionality | Scalability
SPEED | FUNCTIONALITY | SCALABILITY
Slide 39: Competition – Legacy Technology
Competition – Legacy Technology “Compress & Send” PACS MODALITIES RADIOLOGIST/CLINICIAN
Slide 40: Pro Medicus – Solution
Pro Medicus – Solution “Streaming Technology” MODALITIES RADIOLOGIST/CLINICIAN
Slide 41: Driver – Massive Data Explosion
Driver – Massive Data Explosion • Photon-Counting CT – .2 mm; 10,000+ images • HD Breast Tomosynthesis – 6 GB+ • Digital Pathology – 10 GB+ with cystology up to 30 GB • Optoacoustic Breast Ultrasound – 10 GB+ • Total Body PET Scan – 10 GB+ • 7T MRI – much larger than 3T
Slide 42: Driver – Radiologist Burnout – The New Epidemic
Driver – Radiologist Burnout – The New Epidemic • Acute worldwide shortage of radiologists • Reduced intake of radiology residents – fears AI would take over • Larger datasets – more images to look at • Work life balance post COVID – work from home mandatory part of the mix • Many groups struggling
Slide 43: Visage 7 CloudPACS
Visage 7 CloudPACS • Visage 7 – fully Cloud native • Same ultrafast performance as on-premise • Full Visage 7 functionality • Security and scale of the cloud • Suitable for all size implementations • Pipeline opportunities mandating Cloud deployment • Cloud vendor agnostic – large scale implementati
Slide 44: Visage 7 Open Archive
Visage 7 Open Archive • Same highly scalable Visage 7 platform • Interoperable – works in complex environments • Enables choice of modular or single vendor solutions • Visage 7 Open Archive integral part of “Full Stack” solution • Pipeline – most opportunities include Visage 7 Open Archive • Key com
Slide 45: Visage 7 Workflow
Visage 7 Workflow • Adds to Viewer and Open Archive modules • Based on over 30 years experience in Workflow SW • Allows PME to offer “full stack” solution • Integral part of Visage CloudPACS SaaS solution • Ability to interface with broad range of AI algorithms • Sold in majority of new contracts •
Slide 46: Visage 7 | Reporting
Visage 7 | Reporting • Announced at SIIM 2026 • First implementations during 2026 • Native, ultrafast, AI optimized reporting • Intelligent AI tools improve quality and save valuable time • Draft From Prior • Revise tools • Auto Impression generation • Error checking
Slide 47: Visage | Cardiology Imaging
Visage 7 | Cardiology Imaging • Cloud-based Workflow and Imaging Solution for Cardiology Imaging • Same code base as Visage 7 platform • Ultrafast, immediate access to massive Cardiology datasets • Native Cardiology Imaging tools • Advanced interoperability – export measurements to Epic Cupid
Slide 48: Visage | Digital Pathology
Visage 7 | Digital Pathology • Native support within the Visage 7 Enterprise Imaging Platform • Fully Cloud-based (Visage 7 | CloudPACS) • Spatial computing support via Visage Ease VP for Apple Vision Pro • Validation of IHE Digital Pathology Profile at the 2025 IHE-Europe Connectathon
Slide 49: Visage RIS screenshot
Wo Est Appointment Mr John SMITH 104 S910 10. le 05-08-1977 (40y) ¢* H: (03) 12121211 Visage General Hospital Vi Medium prosmedicus — Visace IMAGING’
Slide 50: Visage RIS
Visage RIS • Long term (5 year) contracts with Lumus (Primary Healthcare) and I-MED, the 2 biggest radiology providers in AUS • Upside via client organic and M&A growth • Increased market interest – new opportunities • PME undisputed market leader
Slide 51: Clinical Outcomes
% progmedicus — Visace IMAGING’ Clinical Outcomes prosmedicus — Visace IMAGING’
Slide 52: Delivering Clinical Outcomes
Delivering Clinical Outcomes Moving the Needle
Slide 53: Delivering Clinical Outcomes & Proven ROI
Delivering Clinical Outcomes & Proven ROI Significant IT & Unparalleled Increase in Greater Clinical Accuracy Infrastructure Savings Radiologist Efficiency Improved Physician Delivers Superior Engagement Value Proposition
Slide 54: Growth Strategy
% progmedicus — Visace IMAGING’ Growth Strategy prosmedicus — Visace IMAGING’
Slide 55: Growth Strategy
Growth Strategy 2 3 Grow Existing Clients Launch New products 1 4 Win New Clients Enter New Geographies
Slide 56: North American – TAM
North American – TAM • 690 Million exams performed per annum in the US • Growing by ~3% per year • In contrast, Visage customers are growing by ~8% • Visage able to address 100% of TAM from a product perspective • ~ 85% of TAM addressable from commercial perspective – “full stack”, cloud etc… • Curr
Slide 57: North American Pipeline
North American Pipeline Pipeline Robust Opportunities Network Effect Prospects In terms of quality and Increased number of Further increased from recent Progressing through quantity of opportunities inbound RFPs high-profile wins in both Tier-1 various stages of the cycle academic and IDN markets
Slide 58: Largest Footprint in AMC
Largest Footprint in AMC 2026/2027 Best Hospitals (alphabetical order) >50% of the Best Rated U.S. Hospitals (11 out of 20) use Visage 7 for PACS
Slide 59: IDN Segment – Growing Footprint
IDN Segment – Growing Footprint • IDNs represent the largest segment of the market • IDN clients across broad spectrum of opportunities from large, national, multi-state, to smaller regional • Most recent IDN sales for more than one Visage product – many “full stack” + • 100% cloud deployments since
Slide 60: Private Market Segment
Private Market Segment • Previously “dormant” due to increased M&A activity • RANT (ARM) A$44M 5-year deal • Adds to A$70M contracted in private market in FY25 • Confirms Visage platform suited to broad range of market segments • Opens more opportunities in this market space
Slide 61: RSNA 2025
% progmedicus — Visace IMAGING’ RSNA 2025 prosmedicus — Visace IMAGING’
Slide 62: Visage Ease VP for Apple Vision Pro
Visage Ease VP for Apple Vision Pro “Underpins our belief that our technology is 18 to 24 months ahead of competitors, if not more.”
Slide 63: Apple Store Event – RSNA 2025
Apple Store Event — RSNA 2025 prosmedicus — Visace IMAGING’
Slide 64: Pro Medicus – RSNA 2025
Pro Medicus — RSNA 2025 prosmedicus — Visace IMAGING’
Slide 65: Summary
% progmedicus — Visace IMAGING’ Summary prosmedicus — Visace IMAGING’
Slide 66: Summary
Summary • Record Financials – Underlying Revenue +28%1, Underlying EBIT +31%2, Underlying NPAT +33%2, Cash Conversion 91%, Cash & Other Financial Assets $252m + 20% • Cloud – Huge strategic advantage over competitors • Contract Wins – Majority “full stack”, 10 contracts signed worth total of A$407m
Slide 67: Thank You
% _ pro¢medicus | VISAGE IMAGING’ Thank You y i